Trade SEPN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Septerna, Inc. (SEPN) is trading at US$39.25, down 3.02% today as of Aug 28, 12:38 EDT. The company has a market capitalisation of US$1.87B. Over the past 52 weeks, SEPN has traded between US$11.70 and US$51.10. On Syfe you can trade SEPN with $0 commission and add it to your watchlist.
| Previous close | US$40.47 |
|---|---|
| Market cap | US$1.87B |
| 52-week range | US$11.70 – US$51.10 |
| Volume | 266.54K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Septerna, Inc.
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Year: 2024
--Truist Securities Adjusts Septerna Price Target to $43 From $35, Maintains Buy Rating
Jul 1, 12:46 PM · MT Newswires
Guggenheim Initiates Septerna at Buy With $52 Price Target
Jun 11, 10:40 AM · MT Newswires
Septerna, Inc. (SEPN) stock is trading at US$39.25, -3.02% from the previous close of US$40.47.
The market cap for Septerna, Inc. (SEPN) stock is approximately US$1.87B.
The 52-week high for Septerna, Inc. (SEPN) stock is US$51.10.
The 52-week low for Septerna, Inc. (SEPN) stock is US$11.70.
Septerna, Inc. (SEPN) does not currently pay a dividend.
Stay on top of SEPN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
